Acquired a US patent for the core technology of the proprietary AI engine "Concept Encoder"

2022.10.27 Press release

--To the press -

Acquired a US patent for the core technology of the proprietary AI engine "Concept Encoder"

Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Growth)

 FRONTEO Co., Ltd. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter referred to as FRONTEO) is the core technology of its proprietary AI engine "Concept Encoder (trademark: conceptencoder, reading: concept encoder)". We are pleased to inform you that we have received a patent allowance notice from the United States Patent and Trademark Office for our index value calculation device, similarity search device, and similarity index value calculation program.This is the second country, following Japan (patent registered on June 2018, 6), to have the patentability of this technology recognized.

   (Similarity Index Value Calculation Device, Similarity Search Device, and Similarity Index Value Calculation Program)
Application number: 16/759,474 *No registration number assigned
Filing date: January 2020, 4

 FRONTEO is working on research and development of advanced and advanced AI technology that contributes to solving various social issues, and acquiring patents for them in Japan and overseas.We believe that this patent grant is an important step for FRONTEO to expand its business related to AI systems and applications using Concept Encoder overseas.

 FRONTEO will continue to contribute to solving social issues and realizing the fairness of the information society through research and development and commercialization of its own AI technology.

 The impact of this matter alone on the business results for the current fiscal year is minor, but we will promptly notify you if there are any matters to be disclosed.


■ About Concept Encoder URL:
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specializing in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data, including large amounts of free-form text data, based on evidence. "Concept Encoder" can also be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vital signs, and various test values ​​that have been accumulated in the life science field.Patent registration number: Patent No. 6346367

FRONTEO uses the in-house developed AI engines "KIBIT", "Concept Encoder (trademark: conceptencoder, reading: concept encoder)", and "Looca Cross", which are specialized in natural language processing. It is a data analysis company that supports the business of companies by extracting meaningful and important information from a huge amount of text data. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support corporate international litigation. Has been deployed.Based on the AI ​​technology cultivated in this business, we will expand the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge", We contribute to solving various corporate issues such as drug discovery support, dementia diagnosis support, financial, personnel, and sales support. Listed on TSE Mothers (currently TSE Growth) on June 2014, 2007. Obtained a first-class medical device manufacturing and sales business license in January 6 (permit number: 26B2021X1), and notified the managed medical device sales business in September of the same year (notification number: 13 Minato Misei Equipment No. 1).The capital is 10350 thousand yen (as of March 9, 3).

* FRONTEO, KIBIT, conceptencoder, and Looca Cross are registered trademarks of FRONTEO in Japan.


<Contact information for the press>
Public Relations Officer, FRONTEO Inc.

<Inquiries about Life Science AI Business>
FRONTEO Inc. Life Science AI Business Headquarters

ja 日本語
Machine Translation by Google. : close x